Growth Metrics

HeartSciences (HSCS) Share-based Compensation (2021 - 2026)

HeartSciences filings provide 6 years of Share-based Compensation readings, the most recent being -$503107.0 for Q1 2026.

  • On a quarterly basis, Share-based Compensation changed N/A to -$503107.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $268926.0, a 203.9% increase, with the full-year FY2025 number at $170637.0, down 57.87% from a year prior.
  • Share-based Compensation hit -$503107.0 in Q1 2026 for HeartSciences, down from $436884.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $436884.0 in Q4 2025 to a low of -$503107.0 in Q1 2026.
  • Median Share-based Compensation over the past 5 years was $99154.0 (2023), compared with a mean of $66552.2.
  • Biggest five-year swings in Share-based Compensation: soared 8956.68% in 2022 and later crashed 98.69% in 2023.
  • HeartSciences' Share-based Compensation stood at $1918.0 in 2022, then surged by 5418.25% to $105840.0 in 2023, then tumbled by 90.51% to $10046.0 in 2024, then skyrocketed by 4248.84% to $436884.0 in 2025, then plummeted by 215.16% to -$503107.0 in 2026.
  • The last three reported values for Share-based Compensation were -$503107.0 (Q1 2026), $436884.0 (Q4 2025), and $174558.0 (Q3 2025) per Business Quant data.